Mayne Pharma Group (MAYNF) Stock Price, News & Analysis

Company Overview

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Key Stats

• Today's Range: $2.85 to $2.85
• 50-Day Range: $2.85 to $4.43
• 52-Week Range: $2.42 to $4.60
• Volume: N/A
• Average Volume: 1,829 shs
• Market Capitalization: N/A
• P/E Ratio: 79.17
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MAYNF Stock Analysis - Frequently Asked Questions

How have MAYNF shares performed this year?

Mayne Pharma Group's stock was trading at $2.79 at the beginning of the year. Since then, MAYNF stock has increased by 2.2% and is now trading at $2.85.
View the best growth stocks for 2025 here.

When did Mayne Pharma Group's stock split?

Mayne Pharma Group's stock reverse split on Wednesday, January 18th 2023. The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Mayne Pharma Group?

Shares of MAYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MAYNF
• CIK: N/A
• Web: www.maynepharma.com
• Phone: (188) 209-2666
• Fax: N/A
• Employees: 780
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 79.17
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A